All resources

This guidance is for ambulance services which need to administer diazepam, a medicine for treating seizures, to neonates and infants. It explains how to accurately administer a 1.25mg or 2.5mg dose directly from a 5mg rectal tube. Buccal midazolam is usually preferred to rectal diazepam in the ho...

Drug allergy is a reaction to a medicinal product. This is one of several allergy care pathways, which tell health professionals what they need to know in order to provide the best care possible.

Following the known harms of valproate in pregnancy, MHRA released a report looking into the safety data for epilepsy medicines during pregnancy.

During the transition period, RCPCH called on Government to put children and young people’s best interest at the centre of its negotiations with the European Union. We summarise and review the agreements made in the UK-EU deal that will impact on child health and our members.

The Royal College of Paediatrics and Child Health and British Paediatric Neurology Association has developed this Q&A in light of recent developments in this area. It advises on the legality and safety of cannabis-based products and considers the evidence base for their potential harms and benefits.

We are very pleased to announce the publication of this latest position statement produced by the Neonatal and Paediatric Pharmacy Group (NPPG) and endorsed by the Royal College of Paediatrics and Child Health (RCPCH) regarding how to choose an oral liquid for a child.

The following case study from Calderdale and Huddersfield NHS Foundation Trust was included in the 2018 annual report on 2017 data, and highlights how NNAP results can be used as a basis for identifying, and undertaking, local quality improvement activities.

This statement is produced by Neonatal and Paediatric Pharmacy Group (NPPG), with support from RCPCH. There are no licensed oral liquid calcium or phosphate products available in the UK. Administration of an effervescent calcium or phosphate tablet is common, and this statement provides guidance for...

The purpose of this position statement is to clarify the current criteria in making a diagnosis of hEDS in children and adolescents and to provide advice to paediatric health professionals in relation to provision of appropriate rehabilitation.